Evaluation of Trends in Preexposure Prophylaxis Prescriptions During the First 6 Months of the COVID-19 Pandemic in New York State

O'Grady, Thomas; Tesoriero, James M.; Yuan, Yingchao; Grisham, Thomas M; Seo, Sang-Beom; Gonzalez, Charles J.; Morne, Johanne E.

doi:10.1001/jamanetworkopen.2022.4065

Cited by 3 publications

(2 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These results confirm the major impact of the COVID-19 pandemic on PrEP use in France, as already reported for other health products 17 , 18 , 28 and in other countries. 20 , 22 , 29 , 30 In addition, they draw attention to the substantial frequency of early PrEP discontinuation. The negative impact of PrEP discontinuation on its real-life preventive effectiveness was demonstrated in a recent study conducted by our team.…”

Section: Discussionmentioning

confidence: 99%

Roll-out of HIV pre-exposure prophylaxis use in France: A nationwide observational study from 2016 to 2021

Gage¹,

Desplas²,

Dray‐Spira³

2022

The Lancet Regional Health - Europe

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Roll-out of HIV pre-exposure prophylaxis use in France: A nationwide observational study from 2016 to 2021

Gage¹,

Desplas²,

Dray‐Spira³

2022

The Lancet Regional Health - Europe

View full text Add to dashboard Cite

“…Discerning the impact of PAW was made challenging by the closely timed seasonal impacts of Thanksgiving and Christmas and the relatively post-PAW observation period due to the COVID-19 pandemic, which significantly reduced PrEP prescriptions in NYS. 23 These data do not permit an understanding of the mechanism by which PAW increased PrEP prescriptions (ie, how persons were exposed to the campaign, how much of the impact was consumer vs provider driven, etc) or the relationship between the increased prescriptions and unmet need for PrEP. Race and ethnicity were missing or unknown for 30% of total prescriptions and 40% of new prescriptions.…”

Section: Implications For Policy and Practicementioning

confidence: 99%

Assessing the Impact of a PrEP Aware Week Campaign on PrEP Prescription Fills in NYS

Tesoriero

Yuan

Newport

et al. 2022

Journal of Public Health Management and Practice

Self Cite

View full text Add to dashboard Cite

Context:The New York State (NYS) Department of Health AIDS Institute engaged stakeholders across NYS to participate in the state's first "PrEP Aware Week" (PAW). PAW sought to increase the knowledge, interest, and number of PrEP (preexposure prophylaxis) prescriptions filled across NYS. PAW activities were designed to be easy to implement, with minimal cost. Stakeholders were provided activities to implement, along with a social media tool kit featuring videos, graphic ads, and sample social media posts in English and Spanish to use as is or modify. PAW included more than 750 distinct events and activities undertaken by more than 250 participating providers. Objective: To assess the impact of PAW on PrEP prescription filling patterns in NYS. Design: An interrupted time-series analysis was conducted to estimate the impact of PAW on overall and new PrEP prescription filling patterns. Separate models were developed by sex (male, female), race and ethnicity (White non-Hispanic, Black non-Hispanic, Hispanic, other, unknown), and region (New York City, rest of NYS). Setting: PAW took place across NYS during the week beginning October 20, 2019. Participants: PAW was undertaken by more than 250 health care providers, nonmedical health & human services providers, local and state health department staff, and colleges and universities. Main Outcome Measures: The number of overall and new PrEP prescriptions. Results: PAW was associated with modest increases (6%-9%) in the number of PrEP prescription fills in NYS. The PAW impact lasted for about 2 months, generated an estimated 2727 additional PrEP prescription fills statewide, and was realized across sex, region, and racial and ethnic subgroups. Increased prescription fills were driven by those previously prescribed PrEP. Increases in new prescriptions were noted among Latinx individuals (21% increase, 55 additional prescriptions) but not overall or across other groups. Conclusion: NYS's PAW was effective at increasing PrEP prescription refills in NYS.

show abstract

Incidence of Sexually Transmitted Infections in Youth with HIV During Pre-COVID and COVID Era

Khan,

Loerinc,

Scheel

et al. 2024

AIDS Patient Care and STDs

View full text Add to dashboard Cite

Evaluation of Trends in Preexposure Prophylaxis Prescriptions During the First 6 Months of the COVID-19 Pandemic in New York State

Abstract: This cohort study uses time-series models to estimate preexposure prophylaxis prescription trends during the first 6 months of the COVID-19 pandemic in New York State in 2020.

Cited by 3 publications

References 4 publications

Roll-out of HIV pre-exposure prophylaxis use in France: A nationwide observational study from 2016 to 2021

Roll-out of HIV pre-exposure prophylaxis use in France: A nationwide observational study from 2016 to 2021

Assessing the Impact of a PrEP Aware Week Campaign on PrEP Prescription Fills in NYS

Incidence of Sexually Transmitted Infections in Youth with HIV During Pre-COVID and COVID Era

Contact Info

Product

Resources

About